Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
The effects of chemotherapeutic agents on differentiated chordoma cells.
Bayrak OF, Aydemir E, Gulluoglu S, Sahin F, Sevli S, Yalvac ME, Acar H, Ozen M. Bayrak OF, et al. J Neurosurg Spine. 2011 Dec;15(6):620-4. doi: 10.3171/2011.7.SPINE10798. Epub 2011 Sep 9. J Neurosurg Spine. 2011. PMID: 21905773
Differentiation therapy, using various differentiating agents, is attracting oncologists as a common therapeutic method to treat other tumors. ...CONCLUSIONS: The results suggest that chordoma cells may be treated using the differentiation
Differentiation therapy, using various differentiating agents, is attracting oncologists as a common therapeutic method
Characterization and analysis of human chordoma cell lines.
Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J, Rosenberg A, Nielsen GP, Xavier RJ, Mankin H, Duan Z. Yang C, et al. Spine (Phila Pa 1976). 2010 Jun 1;35(13):1257-64. doi: 10.1097/BRS.0b013e3181c2a8b0. Spine (Phila Pa 1976). 2010. PMID: 20461036 Free PMC article.
Additionally, the sensitivity of the 3 chordoma cell lines to 6 chemotherapeutic drugs was analyzed. RESULTS: CH 8, GP 60, and U-CH1 cells proliferate more actively in Iscove Modified Dulbecco Medium or Dulbecco modified Eagle Medium and less actively …
Additionally, the sensitivity of the 3 chordoma cell lines to 6 chemotherapeutic drugs was analyzed. RESULTS: CH 8, GP …
Feedback